163 related articles for article (PubMed ID: 21509863)
1. Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics.
Wang Y; Chen ZE; Yaghmai V; Nikolaidis P; McCarthy RJ; Merrick L; Miller FH
J Magn Reson Imaging; 2011 May; 33(5):1071-9. PubMed ID: 21509863
[TBL] [Abstract][Full Text] [Related]
2. Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient.
Matoba M; Tonami H; Kondou T; Yokota H; Higashi K; Toga H; Sakuma T
Radiology; 2007 May; 243(2):570-7. PubMed ID: 17400757
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted magnetic resonance imaging in differentiation of postobstructive consolidation from central lung carcinoma.
Baysal T; Mutlu DY; Yologlu S
Magn Reson Imaging; 2009 Dec; 27(10):1447-54. PubMed ID: 19553048
[TBL] [Abstract][Full Text] [Related]
4. Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions.
Kang KM; Lee JM; Yoon JH; Kiefer B; Han JK; Choi BI
Radiology; 2014 Feb; 270(2):444-53. PubMed ID: 24126370
[TBL] [Abstract][Full Text] [Related]
5. Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging.
Kim SY; Lee SS; Byun JH; Park SH; Kim JK; Park B; Kim N; Lee MG
Radiology; 2010 Jun; 255(3):815-23. PubMed ID: 20501719
[TBL] [Abstract][Full Text] [Related]
6. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
[TBL] [Abstract][Full Text] [Related]
7. The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors.
Jang KM; Kim SH; Lee SJ; Choi D
Acta Radiol; 2014 Mar; 55(2):140-8. PubMed ID: 23897307
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors?
Habermann CR; Gossrau P; Graessner J; Arndt C; Cramer MC; Reitmeier F; Jaehne M; Adam G
Rofo; 2005 Jul; 177(7):940-5. PubMed ID: 15973595
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer: lack of association between apparent diffusion coefficient values and adverse pathological features.
Rosenkrantz AB; Matza BW; Sabach A; Hajdu CH; Hindman N
Clin Radiol; 2013 Apr; 68(4):e191-7. PubMed ID: 23312674
[TBL] [Abstract][Full Text] [Related]
10. Soft-tissue tumors evaluated by line-scan diffusion-weighted imaging: influence of myxoid matrix on the apparent diffusion coefficient.
Maeda M; Matsumine A; Kato H; Kusuzaki K; Maier SE; Uchida A; Takeda K
J Magn Reson Imaging; 2007 Jun; 25(6):1199-204. PubMed ID: 17520732
[TBL] [Abstract][Full Text] [Related]
11. Pediatric abdominal masses: diagnostic accuracy of diffusion weighted MRI.
Kocaoglu M; Bulakbasi N; Sanal HT; Kismet E; Caliskan B; Akgun V; Tayfun C
Magn Reson Imaging; 2010 Jun; 28(5):629-36. PubMed ID: 20378294
[TBL] [Abstract][Full Text] [Related]
12. Intravoxel incoherent motion diffusion-weighted imaging of pancreatic neuroendocrine tumors: prediction of the histologic grade using pure diffusion coefficient and tumor size.
Hwang EJ; Lee JM; Yoon JH; Kim JH; Han JK; Choi BI; Lee KB; Jang JY; Kim SW; Nickel MD; Kiefer B
Invest Radiol; 2014 Jun; 49(6):396-402. PubMed ID: 24500090
[TBL] [Abstract][Full Text] [Related]
13. Apparent diffusion coefficient in pancreatic cancer: characterization and histopathological correlations.
Muraoka N; Uematsu H; Kimura H; Imamura Y; Fujiwara Y; Murakami M; Yamaguchi A; Itoh H
J Magn Reson Imaging; 2008 Jun; 27(6):1302-8. PubMed ID: 18504750
[TBL] [Abstract][Full Text] [Related]
14. Differentiation between pancreatic carcinoma and mass-forming chronic pancreatitis: usefulness of high b value diffusion-weighted imaging.
Huang WC; Sheng J; Chen SY; Lu JP
J Dig Dis; 2011 Oct; 12(5):401-8. PubMed ID: 21955434
[TBL] [Abstract][Full Text] [Related]
15. Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity.
Humphries PD; Sebire NJ; Siegel MJ; Olsen ØE
Radiology; 2007 Dec; 245(3):848-54. PubMed ID: 17951348
[TBL] [Abstract][Full Text] [Related]
16. [Value of dynamic enhanced magnetic resonance in diagnosis of pancreatic carcinoma and endocrine tumors].
Lu GM; Wang ZQ; Zheng L; Wang JP; Qiu XM; Tang XJ
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):951-4. PubMed ID: 16759532
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses.
Lee SS; Byun JH; Park BJ; Park SH; Kim N; Park B; Kim JK; Lee MG
J Magn Reson Imaging; 2008 Oct; 28(4):928-36. PubMed ID: 18821618
[TBL] [Abstract][Full Text] [Related]
18. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
[TBL] [Abstract][Full Text] [Related]
19. Hepatic hemangioma: correlation of enhancement types with diffusion-weighted MR findings and apparent diffusion coefficients.
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Kajita K; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
Eur J Radiol; 2009 May; 70(2):325-30. PubMed ID: 18321673
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MR imaging in the evaluation of renal tumours.
Squillaci E; Manenti G; Di Stefano F; Miano R; Strigari L; Simonetti G
J Exp Clin Cancer Res; 2004 Mar; 23(1):39-45. PubMed ID: 15149149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
